About: Ribavirin, viramidine and adenosine-deaminase-catalysed drug activation: implication for nucleoside prodrug design

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Ribavirin, viramidine and adenosine-deaminase-catalysed drug activation: implication for nucleoside prodrug design Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Ribavirin, viramidine and adenosine-deaminase-catalysed drug activation: implication for nucleoside prodrug design
Creator	Hong, Zhi Lin, Chin-Chung Wu, Jim
Source	Medline; PMC
abstract	covid:135c2bacad3145424e8db55c9de4218015b366c3#abstract
has issue date	2003-10-01(xsd:dateTime)
bibo:doi	10.1093/jac/dkg405
bibo:pmid	12951339
has license	no-cc
sha1sum (hex)	135c2bacad3145424e8db55c9de4218015b366c3
schema:url	https://doi.org/10.1093/jac/dkg405
resource representing a document's title	Ribavirin, viramidine and adenosine-deaminase-catalysed drug activation: implication for nucleoside prodrug design
has PubMed Central identifier	PMC7110004
has PubMed identifier	12951339
schema:publication	J Antimicrob Chemother
resource representing a document's body	covid:135c2bacad3145424e8db55c9de4218015b366c3#body_text
is schema:about of	named entity 'antiviral' named entity 'incorporation' named entity 'antiviral' named entity 'ribavirin' named entity 'ribonucleosides' named entity 'triphosphate' named entity 'purine' named entity 'represent' named entity 'unique' named entity 'nucleoside' named entity 'ribavirin' named entity 'antiviral' named entity 'mechanisms' named entity 'mediated' named entity 'T cell' named entity 'remains' named entity 'confer' named entity 'broad-spectrum' named entity 'activation' named entity 'ADENOSINE' named entity 'SHOWDOMYCIN' named entity '180' named entity 'GLOBAL HEALTH' named entity 'RTP ' named entity 'TRANSITION MUTATIONS' named entity 'DATA' named entity 'ADENOSINE' named entity '2C4' named entity 'PROPERTIES' named entity 'NUMBER OF' named entity 'FIGURE' named entity 'SHIFTING' named entity 'PURINE RIBONUCLEOSIDES' named entity 'TESTING' named entity 'SUBSTRATE' named entity 'RECENT' named entity 'VIRAL PATHOGENS' named entity 'TARGET' named entity 'T CELL MEDIATED IMMUNITY' named entity 'SERIES' named entity 'TRIAZOLE' named entity 'ANALOGUE' named entity 'CAP STRUCTURE' named entity 'COFACTOR' named entity 'DRUG' named entity 'BROAD' named entity 'ENHANCING' named entity 'PYRAZOMYCIN' named entity 'HAND' named entity 'SIGNIFICANT ACTIVITY' named entity 'OXYGEN' named entity 'IMMUNOMODULATOR' named entity 'REVIEW OF' named entity '80%' named entity 'ELIMINATION' named entity 'CAUSED BY' named entity 'DEMAND' named entity 'SPECTRUM' named entity 'DEFECTIVE' named entity 'HOST' named entity 'DIRECT' named entity 'ANTIVIRAL ACTIVITY' named entity 'CELL CULTURE' named entity 'GUANOSINE' named entity 'GTP' named entity 'INOSINE' named entity 'BASED' named entity 'VIRUS' named entity 'POOLS' named entity 'CLINICAL SETTING' named entity 'CASE' named entity 'PRODRUG' named entity 'PHOSPHATE' named entity 'BRIEF' named entity 'RIBONUCLEOSIDES' named entity 'VIRAL GENOME' named entity 'PROFILE' named entity 'RIBOFURANOSYL' named entity 'PATHOGENIC'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software